Urotherapy: Diagnosis and first-line treatment (urotherapy) will be conducted per European Association of Urology (EAU) guidelines.
The primary aim of this study is to evaluate the role of three specific urinary proteins-RhoA, Nerve Growth Factor (NGF), and Brain-Derived Neurotrophic Factor (BDNF)-as potential biomarkers for the diagnosis and follow-up of children aged 4-18 diagnosed with Overactive Bladder (OAB) and Vitamin D deficiency.
| Facility | City | Region | Status |
|---|---|---|---|
| Marmara University School of Medicine Urology Department | Pendik | Istanbul |
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07513363 on ClinicalTrials.gov ↗ ← All trials in Turkey